Evidence map›Paper›PMID 32332698›Full record

ArticleCell death & disease2020

FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling.

Rui Zhao, Linli Tian, Bo Zhao, Yanan Sun, Jing Cao, Kexin Chen, Fengqing Li, Minghua Li, Desi Shang, Ming Liu

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rui Zhao *Department of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Linli Tian *Department of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Bo ZhaoCollege of Life Science, Northeast Forestry University, Harbin, China.
Yanan SunDepartment of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jing CaoDepartment of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Kexin ChenDepartment of Pathology, the Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Fengqing LiDepartment of Gerontology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Minghua LiDepartment of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Desi ShangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. sds_46@163.com.
Ming LiuDepartment of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. liumingent@163.com.ORCID http://orcid.org/0000-0002-5957-0142
Harbin Medical University · CNNortheast Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic abnormality is the major feature of laryngeal squamous cell carcinoma (LSCC), however, the underlying mechanism remain largely elusive. Fatty acid desaturase 1 (FADS1), as the key rate-limiting enzyme of polyunsaturated fatty acids (PUFAs), catalyzes dihomo-gamma-linolenic acid (DGLA) to arachidonic acid (AA). In this study, we reported that the expression of FADS1 was upregulated in LSCC, high FADS1 expression was closely associated with the advanced clinical features and poor prognosis of the recurrent LSCC patients after chemotherapy. Liquid chromatograph-mass spectrometry (LC-MS) analysis revealed that FADS1 overexpression induced greater conversion of DGLA to AA, suggesting an increased activity of FADS1. Similarly, the level of prostaglandin E2 (PGE

Indexed as

AnimalsCarcinoma, Squamous CellDelta-5 Fatty Acid DesaturaseDisease ProgressionFatty Acid DesaturasesHumansLaryngeal NeoplasmsMaleMiceMice, NudeSignal TransductionTOR Serine-Threonine KinasesTransfectionDelta-5 Fatty Acid DesaturaseFADS1 protein, humanFADS1 protein, mouseFatty Acid DesaturasesmTOR protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID32332698
PMCPMC7181692
OpenAlexW3018708983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.